Page 7 - பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை Today - Breaking & Trending Today

INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors


Share this article
Share this article
PLYMOUTH MEETING, Pa., May 17, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced the appointment of Roger D. Dansey, M.D. to its Board of Directors. The appointment adds extensive expertise in drug development to the INOVIO Board as the company strengthens its focus on its late stage product development programs. Currently the Chief Medical Officer at Seagen (formerly Seattle Genetics), Dr. Dansey has played a central role in Seagen s efforts to become a globally recognized, multi product oncology company. ....

South Africa , Ben Matone , Rogerd Dansey , Simonx Benito , Jeff Richardson , Kaneka Eurogentec , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , National Institute Of Allergy , Plumbline Life Sciences , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , International Vaccine Institute , Defense Consortium , Nuclear Defense , Parker Institute For Cancer Immunotherapy , University Of Witwatersrand , Oncology Clinical Research At Gilead Sciences , Department Of Defense Do , National Institutes Of Health , Program Executive Office For Chemical , Stage Oncology At Merck Co Inc , Global Development Lead For Xgeva , Apollobio Corporation , Vaccines Trial Network ,

Gene Editing Expands to New Types of Immune Cells


Gene Editing Expands to New Types of Immune Cells
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytes
News provided by
Share this article
Share this article
SAN FRANCISCO, May 11, 2021 /PRNewswire/ In the decade since the advent of CRISPR-Cas9 gene editing, researchers have used the technology to delete or change genes in a growing number of cell types. Now, researchers at Gladstone Institutes and UC San Francisco (UCSF) have added human monocytes white blood cells that play key roles in the immune system to that list.
A team of scientists at Gladstone Institutes and UC San Francisco led by Alex Marson (left) and Nevan Krogan (right) fine-tuned CRISPR-Cas9 genome editing to help understand how the human immune system fights viruses and microbes. ....

United States , San Francisco , Michaelj Mcgregor , Chan Zuckerberg Biohub , Satishk Pillai , David Wu , Ruthl Kirschstein , Anke Meyer Franke , Jefferys Cox , Theodorel Roth , Youjin Lee , Devin Cavero , Eric Shifrut , Nevan Krogan , Julie Langelier , Weihao Zheng , Kelseym Haas , Juddf Hultquist , Jasona Wojcechowskyj , Mohameds Bouzidi , Joeld Ernst , Alex Marson , Jonathanm Budzik , Krystala Fontaine , Ujjwal Rathore , Davide Gordon ,